Global Patient Registry Software Market to Reach $3.4 Billion by 2030
The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.
New York, March 28, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Patient Registry Software Industry" - https://www.reportlinker.com/p05957648/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
Global Patient Registry Software Market to Reach $3.4 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Patient Registry Software estimated at US$1.4 Billion in the year 2022, is projected to reach a revised size of US$3.4 Billion by 2030, growing at aCAGR of 11.7% over the period 2022-2030. Product Registries, one of the segments analyzed in the report, is projected to record 11% CAGR and reach US$905.4 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Health Service Registries segment is readjusted to a revised 11.2% CAGR for the next 8-year period.
The U.S. Market is Estimated at $411.1 Million, While China is Forecast to Grow at 11% CAGR
The Patient Registry Software market in the U.S. is estimated at US$411.1 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$575.6 Million by the year 2030 trailing a CAGR of 11% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.5% and 9.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR.
Select Competitors (Total 42 Featured)
- Dacima Software, Inc.
- Evado Pty. Ltd.
- FIGmd, Inc.
- Global Vision Technologies, Inc.
- Ifa Systems AG
- Imagetrend, Inc.
- Liaison Technologies
- M2S, Inc.
- McKesson Corporation
- Optum, Inc.
- Velos, Inc.
Read the full report: https://www.reportlinker.com/p05957648/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Patient Registry Software - Global Key Competitors Percentage
Market Share in 2020 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2020 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Patient Registry Software by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR
Table 2: World Historic Review for Patient Registry Software by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 3: World 16-Year Perspective for Patient Registry
Software by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets for Years 2014, 2023 & 2030
Table 4: World Recent Past, Current & Future Analysis for
Product Registries by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR
Table 5: World Historic Review for Product Registries by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 6: World 16-Year Perspective for Product Registries by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030
Table 7: World Recent Past, Current & Future Analysis for
Health Service Registries by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR
Table 8: World Historic Review for Health Service Registries by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 9: World 16-Year Perspective for Health Service
Registries by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2014, 2023 & 2030
Table 10: World Recent Past, Current & Future Analysis for
Disease Registries by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR
Table 11: World Historic Review for Disease Registries by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 12: World 16-Year Perspective for Disease Registries by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030
Table 13: World Recent Past, Current & Future Analysis for
Hospitals & Medical Practices by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR
Table 14: World Historic Review for Hospitals & Medical
Practices by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 15: World 16-Year Perspective for Hospitals & Medical
Practices by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2014, 2023 & 2030
Table 16: World Recent Past, Current & Future Analysis for
Research Centers by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR
Table 17: World Historic Review for Research Centers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 18: World 16-Year Perspective for Research Centers by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030
Table 19: World Recent Past, Current & Future Analysis for
Pharma, Biotech & Medical Device Companies by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2022 through 2030 and % CAGR
Table 20: World Historic Review for Pharma, Biotech & Medical
Device Companies by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 21: World 16-Year Perspective for Pharma, Biotech &
Medical Device Companies by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 22: World Recent Past, Current & Future Analysis for
Government Organizations & TPAs by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR
Table 23: World Historic Review for Government Organizations &
TPAs by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 24: World 16-Year Perspective for Government
Organizations & TPAs by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 25: World Recent Past, Current & Future Analysis for
Other End-Uses by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR
Table 26: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 27: World 16-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030
Table 28: World Patient Registry Software Market Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
Patient Registry Software Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in the United States for 2023
(E)
Table 29: USA Recent Past, Current & Future Analysis for
Patient Registry Software by Registry Type - Product
Registries, Health Service Registries and Disease Registries -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 30: USA Historic Review for Patient Registry Software by
Registry Type - Product Registries, Health Service Registries
and Disease Registries Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 31: USA 16-Year Perspective for Patient Registry Software
by Registry Type - Percentage Breakdown of Value Sales for
Product Registries, Health Service Registries and Disease
Registries for the Years 2014, 2023 & 2030
Table 32: USA Recent Past, Current & Future Analysis for
Patient Registry Software by End-Use - Hospitals & Medical
Practices, Research Centers, Pharma, Biotech & Medical Device
Companies, Government Organizations & TPAs and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 33: USA Historic Review for Patient Registry Software by
End-Use - Hospitals & Medical Practices, Research Centers,
Pharma, Biotech & Medical Device Companies, Government
Organizations & TPAs and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 34: USA 16-Year Perspective for Patient Registry Software
by End-Use - Percentage Breakdown of Value Sales for Hospitals &
Medical Practices, Research Centers, Pharma, Biotech &
Medical Device Companies, Government Organizations & TPAs and
Other End-Uses for the Years 2014, 2023 & 2030
CANADA
Table 35: Canada Recent Past, Current & Future Analysis for
Patient Registry Software by Registry Type - Product
Registries, Health Service Registries and Disease Registries -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 36: Canada Historic Review for Patient Registry Software
by Registry Type - Product Registries, Health Service
Registries and Disease Registries Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 37: Canada 16-Year Perspective for Patient Registry
Software by Registry Type - Percentage Breakdown of Value Sales
for Product Registries, Health Service Registries and Disease
Registries for the Years 2014, 2023 & 2030
Table 38: Canada Recent Past, Current & Future Analysis for
Patient Registry Software by End-Use - Hospitals & Medical
Practices, Research Centers, Pharma, Biotech & Medical Device
Companies, Government Organizations & TPAs and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 39: Canada Historic Review for Patient Registry Software
by End-Use - Hospitals & Medical Practices, Research Centers,
Pharma, Biotech & Medical Device Companies, Government
Organizations & TPAs and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 40: Canada 16-Year Perspective for Patient Registry
Software by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Medical Practices, Research Centers, Pharma,
Biotech & Medical Device Companies, Government Organizations &
TPAs and Other End-Uses for the Years 2014, 2023 & 2030
JAPAN
Patient Registry Software Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Japan for 2023 (E)
Table 41: Japan Recent Past, Current & Future Analysis for
Patient Registry Software by Registry Type - Product
Registries, Health Service Registries and Disease Registries -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 42: Japan Historic Review for Patient Registry Software
by Registry Type - Product Registries, Health Service
Registries and Disease Registries Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 43: Japan 16-Year Perspective for Patient Registry
Software by Registry Type - Percentage Breakdown of Value Sales
for Product Registries, Health Service Registries and Disease
Registries for the Years 2014, 2023 & 2030
Table 44: Japan Recent Past, Current & Future Analysis for
Patient Registry Software by End-Use - Hospitals & Medical
Practices, Research Centers, Pharma, Biotech & Medical Device
Companies, Government Organizations & TPAs and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 45: Japan Historic Review for Patient Registry Software
by End-Use - Hospitals & Medical Practices, Research Centers,
Pharma, Biotech & Medical Device Companies, Government
Organizations & TPAs and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 46: Japan 16-Year Perspective for Patient Registry
Software by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Medical Practices, Research Centers, Pharma,
Biotech & Medical Device Companies, Government Organizations &
TPAs and Other End-Uses for the Years 2014, 2023 & 2030
CHINA
Patient Registry Software Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in China for 2023 (E)
Table 47: China Recent Past, Current & Future Analysis for
Patient Registry Software by Registry Type - Product
Registries, Health Service Registries and Disease Registries -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 48: China Historic Review for Patient Registry Software
by Registry Type - Product Registries, Health Service
Registries and Disease Registries Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 49: China 16-Year Perspective for Patient Registry
Software by Registry Type - Percentage Breakdown of Value Sales
for Product Registries, Health Service Registries and Disease
Registries for the Years 2014, 2023 & 2030
Table 50: China Recent Past, Current & Future Analysis for
Patient Registry Software by End-Use - Hospitals & Medical
Practices, Research Centers, Pharma, Biotech & Medical Device
Companies, Government Organizations & TPAs and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 51: China Historic Review for Patient Registry Software
by End-Use - Hospitals & Medical Practices, Research Centers,
Pharma, Biotech & Medical Device Companies, Government
Organizations & TPAs and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 52: China 16-Year Perspective for Patient Registry
Software by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Medical Practices, Research Centers, Pharma,
Biotech & Medical Device Companies, Government Organizations &
TPAs and Other End-Uses for the Years 2014, 2023 & 2030
EUROPE
Patient Registry Software Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Europe for 2023 (E)
Table 53: Europe Recent Past, Current & Future Analysis for
Patient Registry Software by Geographic Region - France,
Germany, Italy, UK and Rest of Europe Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2022 through
2030 and % CAGR
Table 54: Europe Historic Review for Patient Registry Software
by Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2014 through 2021 and % CAGR
Table 55: Europe 16-Year Perspective for Patient Registry
Software by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK and Rest of Europe Markets
for Years 2014, 2023 & 2030
Table 56: Europe Recent Past, Current & Future Analysis for
Patient Registry Software by Registry Type - Product
Registries, Health Service Registries and Disease Registries -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 57: Europe Historic Review for Patient Registry Software
by Registry Type - Product Registries, Health Service
Registries and Disease Registries Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 58: Europe 16-Year Perspective for Patient Registry
Software by Registry Type - Percentage Breakdown of Value Sales
for Product Registries, Health Service Registries and Disease
Registries for the Years 2014, 2023 & 2030
Table 59: Europe Recent Past, Current & Future Analysis for
Patient Registry Software by End-Use - Hospitals & Medical
Practices, Research Centers, Pharma, Biotech & Medical Device
Companies, Government Organizations & TPAs and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 60: Europe Historic Review for Patient Registry Software
by End-Use - Hospitals & Medical Practices, Research Centers,
Pharma, Biotech & Medical Device Companies, Government
Organizations & TPAs and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 61: Europe 16-Year Perspective for Patient Registry
Software by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Medical Practices, Research Centers, Pharma,
Biotech & Medical Device Companies, Government Organizations &
TPAs and Other End-Uses for the Years 2014, 2023 & 2030
FRANCE
Patient Registry Software Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in France for 2023 (E)
Table 62: France Recent Past, Current & Future Analysis for
Patient Registry Software by Registry Type - Product
Registries, Health Service Registries and Disease Registries -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 63: France Historic Review for Patient Registry Software
by Registry Type - Product Registries, Health Service
Registries and Disease Registries Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 64: France 16-Year Perspective for Patient Registry
Software by Registry Type - Percentage Breakdown of Value Sales
for Product Registries, Health Service Registries and Disease
Registries for the Years 2014, 2023 & 2030
Table 65: France Recent Past, Current & Future Analysis for
Patient Registry Software by End-Use - Hospitals & Medical
Practices, Research Centers, Pharma, Biotech & Medical Device
Companies, Government Organizations & TPAs and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 66: France Historic Review for Patient Registry Software
by End-Use - Hospitals & Medical Practices, Research Centers,
Pharma, Biotech & Medical Device Companies, Government
Organizations & TPAs and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 67: France 16-Year Perspective for Patient Registry
Software by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Medical Practices, Research Centers, Pharma,
Biotech & Medical Device Companies, Government Organizations &
TPAs and Other End-Uses for the Years 2014, 2023 & 2030
GERMANY
Patient Registry Software Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Germany for 2023 (E)
Table 68: Germany Recent Past, Current & Future Analysis for
Patient Registry Software by Registry Type - Product
Registries, Health Service Registries and Disease Registries -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 69: Germany Historic Review for Patient Registry Software
by Registry Type - Product Registries, Health Service
Registries and Disease Registries Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 70: Germany 16-Year Perspective for Patient Registry
Software by Registry Type - Percentage Breakdown of Value Sales
for Product Registries, Health Service Registries and Disease
Registries for the Years 2014, 2023 & 2030
Table 71: Germany Recent Past, Current & Future Analysis for
Patient Registry Software by End-Use - Hospitals & Medical
Practices, Research Centers, Pharma, Biotech & Medical Device
Companies, Government Organizations & TPAs and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 72: Germany Historic Review for Patient Registry Software
by End-Use - Hospitals & Medical Practices, Research Centers,
Pharma, Biotech & Medical Device Companies, Government
Organizations & TPAs and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 73: Germany 16-Year Perspective for Patient Registry
Software by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Medical Practices, Research Centers, Pharma,
Biotech & Medical Device Companies, Government Organizations &
TPAs and Other End-Uses for the Years 2014, 2023 & 2030
ITALY
Table 74: Italy Recent Past, Current & Future Analysis for
Patient Registry Software by Registry Type - Product
Registries, Health Service Registries and Disease Registries -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 75: Italy Historic Review for Patient Registry Software
by Registry Type - Product Registries, Health Service
Registries and Disease Registries Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 76: Italy 16-Year Perspective for Patient Registry
Software by Registry Type - Percentage Breakdown of Value Sales
for Product Registries, Health Service Registries and Disease
Registries for the Years 2014, 2023 & 2030
Table 77: Italy Recent Past, Current & Future Analysis for
Patient Registry Software by End-Use - Hospitals & Medical
Practices, Research Centers, Pharma, Biotech & Medical Device
Companies, Government Organizations & TPAs and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 78: Italy Historic Review for Patient Registry Software
by End-Use - Hospitals & Medical Practices, Research Centers,
Pharma, Biotech & Medical Device Companies, Government
Organizations & TPAs and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 79: Italy 16-Year Perspective for Patient Registry
Software by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Medical Practices, Research Centers, Pharma,
Biotech & Medical Device Companies, Government Organizations &
TPAs and Other End-Uses for the Years 2014, 2023 & 2030
UNITED KINGDOM
Patient Registry Software Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in the United Kingdom for 2023
(E)
Table 80: UK Recent Past, Current & Future Analysis for Patient
Registry Software by Registry Type - Product Registries, Health
Service Registries and Disease Registries - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR
Table 81: UK Historic Review for Patient Registry Software by
Registry Type - Product Registries, Health Service Registries
and Disease Registries Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 82: UK 16-Year Perspective for Patient Registry Software
by Registry Type - Percentage Breakdown of Value Sales for
Product Registries, Health Service Registries and Disease
Registries for the Years 2014, 2023 & 2030
Table 83: UK Recent Past, Current & Future Analysis for Patient
Registry Software by End-Use - Hospitals & Medical Practices,
Research Centers, Pharma, Biotech & Medical Device Companies,
Government Organizations & TPAs and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 84: UK Historic Review for Patient Registry Software by
End-Use - Hospitals & Medical Practices, Research Centers,
Pharma, Biotech & Medical Device Companies, Government
Organizations & TPAs and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 85: UK 16-Year Perspective for Patient Registry Software
by End-Use - Percentage Breakdown of Value Sales for Hospitals &
Medical Practices, Research Centers, Pharma, Biotech &
Medical Device Companies, Government Organizations & TPAs and
Other End-Uses for the Years 2014, 2023 & 2030
REST OF EUROPE
Table 86: Rest of Europe Recent Past, Current & Future Analysis
for Patient Registry Software by Registry Type - Product
Registries, Health Service Registries and Disease Registries -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 87: Rest of Europe Historic Review for Patient Registry
Software by Registry Type - Product Registries, Health Service
Registries and Disease Registries Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 88: Rest of Europe 16-Year Perspective for Patient
Registry Software by Registry Type - Percentage Breakdown of
Value Sales for Product Registries, Health Service Registries
and Disease Registries for the Years 2014, 2023 & 2030
Table 89: Rest of Europe Recent Past, Current & Future Analysis
for Patient Registry Software by End-Use - Hospitals & Medical
Practices, Research Centers, Pharma, Biotech & Medical Device
Companies, Government Organizations & TPAs and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 90: Rest of Europe Historic Review for Patient Registry
Software by End-Use - Hospitals & Medical Practices, Research
Centers, Pharma, Biotech & Medical Device Companies, Government
Organizations & TPAs and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 91: Rest of Europe 16-Year Perspective for Patient
Registry Software by End-Use - Percentage Breakdown of Value
Sales for Hospitals & Medical Practices, Research Centers,
Pharma, Biotech & Medical Device Companies, Government
Organizations & TPAs and Other End-Uses for the Years 2014,
2023 & 2030
ASIA-PACIFIC
Patient Registry Software Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
Table 92: Asia-Pacific Recent Past, Current & Future Analysis
for Patient Registry Software by Registry Type - Product
Registries, Health Service Registries and Disease Registries -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 93: Asia-Pacific Historic Review for Patient Registry
Software by Registry Type - Product Registries, Health Service
Registries and Disease Registries Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 94: Asia-Pacific 16-Year Perspective for Patient Registry
Software by Registry Type - Percentage Breakdown of Value Sales
for Product Registries, Health Service Registries and Disease
Registries for the Years 2014, 2023 & 2030
Table 95: Asia-Pacific Recent Past, Current & Future Analysis
for Patient Registry Software by End-Use - Hospitals & Medical
Practices, Research Centers, Pharma, Biotech & Medical Device
Companies, Government Organizations & TPAs and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 96: Asia-Pacific Historic Review for Patient Registry
Software by End-Use - Hospitals & Medical Practices, Research
Centers, Pharma, Biotech & Medical Device Companies, Government
Organizations & TPAs and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 97: Asia-Pacific 16-Year Perspective for Patient Registry
Software by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Medical Practices, Research Centers, Pharma,
Biotech & Medical Device Companies, Government Organizations &
TPAs and Other End-Uses for the Years 2014, 2023 & 2030
REST OF WORLD
Table 98: Rest of World Recent Past, Current & Future Analysis
for Patient Registry Software by Registry Type - Product
Registries, Health Service Registries and Disease Registries -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 99: Rest of World Historic Review for Patient Registry
Software by Registry Type - Product Registries, Health Service
Registries and Disease Registries Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 100: Rest of World 16-Year Perspective for Patient
Registry Software by Registry Type - Percentage Breakdown of
Value Sales for Product Registries, Health Service Registries
and Disease Registries for the Years 2014, 2023 & 2030
Table 101: Rest of World Recent Past, Current & Future Analysis
for Patient Registry Software by End-Use - Hospitals & Medical
Practices, Research Centers, Pharma, Biotech & Medical Device
Companies, Government Organizations & TPAs and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 102: Rest of World Historic Review for Patient Registry
Software by End-Use - Hospitals & Medical Practices, Research
Centers, Pharma, Biotech & Medical Device Companies, Government
Organizations & TPAs and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 103: Rest of World 16-Year Perspective for Patient
Registry Software by End-Use - Percentage Breakdown of Value
Sales for Hospitals & Medical Practices, Research Centers,
Pharma, Biotech & Medical Device Companies, Government
Organizations & TPAs and Other End-Uses for the Years 2014,
2023 & 2030
IV. COMPETITION
Read the full report: https://www.reportlinker.com/p05957648/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
